USX:SURF - Surface Oncology Inc Surface Oncology Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 2 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price) Note: This stock seems to be inactive

USD 1.07    +0.0 (+0%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

12 Sep 2023


Loading...
Loading...
Loading...

General

CEO: Dr. Robert W. Ross M.D.

IPO: 2018-04-19

Headquarters: US

Employees: 35

Homepage

Description

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors in the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out throughout the region of the United States.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server Fundamental

About · FAQs · StocksCafe © 2024 · Privacy · Terms